Literature DB >> 24464694

Faecal Escherichia coli from patients with E. coli urinary tract infection and healthy controls who have never had a urinary tract infection.

Karen L Nielsen1,2, Pia Dynesen3, Preben Larsen4, Niels Frimodt-Møller1,2.   

Abstract

Urinary tract infections (UTIs) are primarily caused by Escherichia coli with the patient's own faecal flora acting as a reservoir for the infecting E. coli. Here we sought to characterize the E. coli faecal flora of UTI patients and healthy controls who had never had a UTI. Up to 20 E. coli colonies from each rectal swab were random amplified polymorphic DNA (RAPD) typed for clonality, dominance in the sample and correlation to the infecting UTI isolate in patients. Each distinct clone was phylotyped and tested for antimicrobial susceptibility. Eighty-seven per cent of the UTI patients carried the infecting strain in their faecal flora, and faecal clones causing UTI were more often dominant in the faecal flora. Patients had a larger diversity of E. coli in their gut flora by carrying more unique E. coli clones compared to controls, and patient faecal clones were more often associated with multidrug resistance compared to controls. We found a similar phylotype distribution of faecal clones from UTI patients and healthy controls, including a large proportion of B2 isolates in the control group. Faecal-UTI isolates from patients were more often associated with multidrug resistance compared to faecal-only clones, indicating a link between UTI virulence and antimicrobial resistance. Intake of any antibiotic less than 6 months prior to inclusion in the experiment occurred significantly more in patients with UTI than in controls. In contrast, presence of an intrauterine device was significantly more common in controls indicating a protective effect against UTI. In conclusion, healthy controls have a large proportion of potentially pathogenic E. coli phylotypes in their faecal flora without this causing infection.

Entities:  

Mesh:

Year:  2014        PMID: 24464694     DOI: 10.1099/jmm.0.068783-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  34 in total

Review 1.  [Urinary tract infections in the elderly].

Authors:  Klaus Friedrich Becher; Ingo Klempien; Andreas Wiedemann
Journal:  Z Gerontol Geriatr       Date:  2015-08-29       Impact factor: 1.281

2.  Colonization with Escherichia coli Strains among Female Sex Partners of Men with Febrile Urinary Tract Infection.

Authors:  Peter Ulleryd; Torsten Sandberg; Flemming Scheutz; Connie Clabots; Brian D Johnston; Paul Thuras; James R Johnson
Journal:  J Clin Microbiol       Date:  2015-04-01       Impact factor: 5.948

3.  Molecular epidemiology of NDM-1-producing Enterobacteriaceae and Acinetobacter baumannii isolates from Pakistan.

Authors:  Anna L Sartor; Muhammad W Raza; Shahid A Abbasi; Kathryn M Day; John D Perry; David L Paterson; Hanna E Sidjabat
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

4.  Adaptation of Escherichia coli traversing from the faecal environment to the urinary tract.

Authors:  Karen L Nielsen; Marc Stegger; Paul A Godfrey; Michael Feldgarden; Paal S Andersen; Niels Frimodt-Møller
Journal:  Int J Med Microbiol       Date:  2016-11-04       Impact factor: 3.473

5.  Whole-genome comparison of urinary pathogenic Escherichia coli and faecal isolates of UTI patients and healthy controls.

Authors:  Karen Leth Nielsen; Marc Stegger; Kristoffer Kiil; Paul A Godfrey; Michael Feldgarden; Berit Lilje; Paal S Andersen; Niels Frimodt-Møller
Journal:  Int J Med Microbiol       Date:  2017-09-14       Impact factor: 3.473

6.  Evaluation of the Pathogenic Potential of Escherichia coli Strains Isolated from Eye Infections.

Authors:  Pedro Henrique Soares Nunes; Tiago Barcelos Valiatti; Ana Carolina de Mello Santos; Júllia Assis da Silva Nascimento; José Francisco Santos-Neto; Talita Trevizani Rocchetti; Maria Cecilia Zorat Yu; Ana Luisa Hofling-Lima; Tânia Aparecida Tardelli Gomes
Journal:  Microorganisms       Date:  2022-05-25

7.  Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model.

Authors:  Frederik Boetius Hertz; Anders Løbner-Olesen; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

8.  Selection of unique Escherichia coli clones by random amplified polymorphic DNA (RAPD): Evaluation by whole genome sequencing.

Authors:  Karen L Nielsen; Paul A Godfrey; Marc Stegger; Paal S Andersen; Michael Feldgarden; Niels Frimodt-Møller
Journal:  J Microbiol Methods       Date:  2014-06-06       Impact factor: 2.363

Review 9.  The human urobiome.

Authors:  L Brubaker; C Putonti; Q Dong; A J Wolfe
Journal:  Mamm Genome       Date:  2021-03-02       Impact factor: 2.957

10.  Cryptosporidiosis Modulates the Gut Microbiome and Metabolism in a Murine Infection Model.

Authors:  Avinash V Karpe; Melanie L Hutton; Steven J Mileto; Meagan L James; Chris Evans; Rohan M Shah; Amol B Ghodke; Katie E Hillyer; Suzanne S Metcalfe; Jian-Wei Liu; Tom Walsh; Dena Lyras; Enzo A Palombo; David J Beale
Journal:  Metabolites       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.